Results 201 to 210 of about 49,034 (266)

Continuity of care in immune thrombotic thrombocytopenic purpura (iTTP): A visual roadmap for survivorship beyond acute management. [PDF]

Transfusion
Qiao J, Tran MH, Jones J, Simmons S.
europepmc   +1 more source

Clinical characteristics and treatment response of patients with SLE complicated with thrombotic thrombocytopenic purpura. [PDF]

Lupus Sci Med
Zhang K, Zhao P, Huang B, Wang Y, Bi T, Gao P, Wang C, Xing X, Wang N, Feng R, Cheng G, Yao H, An Y, Zhou Y, Jin Y, Li Y, Li Z, He J.   +17 more
europepmc   +1 more source

A Retrospective Analysis of ADAMTS13 Enzymatic Activity Results in a Population With Thrombotic Thrombocytopenic Purpura Disease in the Arabian Gulf and Colombia (APOLO Study). [PDF]

Cureus
Edris S, Aktham Y, Mekky A, Chouikrat MZ, Al Mahdi HB, Younis M, Cortés MA, Vargas MF, Fahmy M.   +8 more
europepmc   +1 more source

Health-related quality of life and mental health in autoimmune thrombotic thrombocytopenic purpura patients in the caplacizumab era. [PDF]

Res Pract Thromb Haemost
Weisinger J, Tites C, Gilardin L, Baba A, Benhamou Y, Azoulay E, Augusto JF, Papo T, Cartery C, Moranne O, Choukroun G, Lièvre L, Fadlallah J, Poullin P, Jaccard A, Presne C, Joly B, Veyradier A, Bouzid R, Coppo P.   +19 more
europepmc   +1 more source

Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS database. [PDF]

Thromb J
Liu Z, Ye X.
europepmc   +1 more source

EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura. [PDF]

Front Immunol
Escribano-Serrat S, Salas MQ, Pascual-Izquierdo C, Fernández Villalobos M, Gómez-Seguí I, Fidalgo T, Fernández Docampo M, Martínez Nieto J, Lamas Ó, Lozano M, Cid J, Charry P, Pino M, Molina P, De Moner B, Ramos Á, Moreno-Castaño AB, Martinez-Sanchez J, Escolar G, Díaz-Ricart M.   +19 more
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura in Pediatric Patients. [PDF]

Biomedicines
Shrestha N, Okpako E, Maitta RW.
europepmc   +1 more source

More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura". [PDF]

Haematologica
Peyvandi F.
europepmc   +1 more source

Idiopathic thrombotic thrombocytopenic purpura

Acta Médica del Centro, 2009
Carmen Garrido Arce, Claudia Roche Albernas, Yanet González Riera, Elvys Pérez Bada, Nadia Patricia Rodríguez Villalta   +4 more
doaj